Literature DB >> 24562591

Herbal medicines for ischemic stroke: combating inflammation as therapeutic targets.

Yong Gu1, Jianping Chen, Jiangang Shen.   

Abstract

Stroke is a debilitating disease for which limited therapeutic approaches are available currently. Thus, there is an urgent need for developing novel therapies for stroke. Astrocytes, endothelial cells and pericytes constitute a neurovascular network for metabolic requirement of neurons. During ischemic stroke, these cells contribute to post-ischemic inflammation at multiple stages of ischemic cascades. Upon ischemia onset, activated resident microglia and astrocytes, and infiltrated immune cells release multiple inflammation factors including cytokines, chemokines, enzymes, free radicals and other small molecules, not only inducing brain damage but affecting brain repair. Recent progress indicates that anti-inflammation is an important therapeutic strategy for stroke. Given a long history with direct experience in the treatment of human subjects, Traditional Chinese Medicine and its related natural compounds are recognized as important sources for drug discovery. Last decade, a great progress has been made to identify active compounds from herbal medicines with the properties of modulating post-ischemic inflammation for neuroprotection. Herein, we discuss the inflammatory pathway in early stage and secondary response to injured tissues after stroke from initial artery occlusion to brain repair, and review the active ingredients from natural products with anti-inflammation and neuroprotection effects as therapeutic agents for ischemic stroke. Further studies on the post-ischemic inflammatory mechanisms and corresponding drug candidates from herbal medicine may lead to the development of novel therapeutic strategies in stroke treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24562591     DOI: 10.1007/s11481-014-9525-5

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  255 in total

1.  Antioxidant profile and early outcome in stroke patients.

Authors:  A Cherubini; M C Polidori; M Bregnocchi; S Pezzuto; R Cecchetti; T Ingegni; A di Iorio; U Senin; P Mecocci
Journal:  Stroke       Date:  2000-10       Impact factor: 7.914

2.  Production of heparin binding epidermal growth factor-like growth factor in the early phase of regeneration after acute renal injury. Isolation and localization of bioactive molecules.

Authors:  M Sakai; M Zhang; T Homma; B Garrick; J A Abraham; J A McKanna; R C Harris
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

3.  Cerebral mast cells regulate early ischemic brain swelling and neutrophil accumulation.

Authors:  Daniel Strbian; Marja-Liisa Karjalainen-Lindsberg; Turgut Tatlisumak; Perttu J Lindsberg
Journal:  J Cereb Blood Flow Metab       Date:  2006-05       Impact factor: 6.200

Review 4.  Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke.

Authors:  Kazuhide Hayakawa; Jianhua Qiu; Eng H Lo
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

5.  Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia.

Authors:  Yasemin Gürsoy-Ozdemir; Alp Can; Turgay Dalkara
Journal:  Stroke       Date:  2004-04-08       Impact factor: 7.914

6.  Surface expression of P-selectin on platelets is related with clinical worsening in acute ischemic stroke.

Authors:  Jae-Kwan Cha; Min-Ho Jeong; Eun-Kyung Kim; Yeong-Jin Lim; Byung-Ryp Ha; Sang-Ho Kim; Jae Woo Kim
Journal:  J Korean Med Sci       Date:  2002-12       Impact factor: 2.153

7.  Protection by tetrahydroxystilbene glucoside against cerebral ischemia: involvement of JNK, SIRT1, and NF-kappaB pathways and inhibition of intracellular ROS/RNS generation.

Authors:  Ting Wang; Jun Gu; Peng-Fei Wu; Fang Wang; Zhe Xiong; Yuan-Jian Yang; Wen-Ning Wu; Ling-Dan Dong; Jian-Guo Chen
Journal:  Free Radic Biol Med       Date:  2009-03-09       Impact factor: 7.376

8.  Protective effect of naringin against ischemic reperfusion cerebral injury: possible neurobehavioral, biochemical and cellular alterations in rat brain.

Authors:  Vaibhav Gaur; Aditi Aggarwal; Anil Kumar
Journal:  Eur J Pharmacol       Date:  2009-07-03       Impact factor: 4.432

9.  The HMGB1 receptor RAGE mediates ischemic brain damage.

Authors:  Sajjad Muhammad; Waleed Barakat; Stoyan Stoyanov; Sasidhar Murikinati; Huan Yang; Kevin J Tracey; Martin Bendszus; Grazisa Rossetti; Peter P Nawroth; Angelika Bierhaus; Markus Schwaninger
Journal:  J Neurosci       Date:  2008-11-12       Impact factor: 6.167

Review 10.  TLR2 and TLR4 in the brain injury caused by cerebral ischemia and reperfusion.

Authors:  Ying Wang; Pengfei Ge; Yuhong Zhu
Journal:  Mediators Inflamm       Date:  2013-06-23       Impact factor: 4.711

View more
  26 in total

1.  Ligustrazine reduces blood-brain barrier permeability in a rat model of focal cerebral ischemia and reperfusion.

Authors:  Feng Tan; Wenjun Fu; Nanfang Cheng; D I Meng; Yong Gu
Journal:  Exp Ther Med       Date:  2015-03-16       Impact factor: 2.447

2.  Phenyl-β-D-Glucopyranoside Exhibits Anti-inflammatory Activity in Lipopolysaccharide-Activated RAW 264.7 Cells.

Authors:  Su Jung Hwang; Hyo-Jong Lee
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

3.  Neuroprotective effect of 6-paradol in focal cerebral ischemia involves the attenuation of neuroinflammatory responses in activated microglia.

Authors:  Bhakta Prasad Gaire; Oh Wook Kwon; Sung Hyuk Park; Kwang-Hoon Chun; Sun Yeou Kim; Dong Yun Shin; Ji Woong Choi
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

4.  An integrated chinmedomics strategy for discovery of effective constituents from traditional herbal medicine.

Authors:  Xijun Wang; Aihua Zhang; Xiaohang Zhou; Qi Liu; Yang Nan; Yu Guan; Ling Kong; Ying Han; Hui Sun; Guangli Yan
Journal:  Sci Rep       Date:  2016-01-11       Impact factor: 4.379

5.  Potential role of microRNA-7 in the anti-neuroinflammation effects of nicorandil in astrocytes induced by oxygen-glucose deprivation.

Authors:  Yin-Feng Dong; Zheng-Zhen Chen; Zhan Zhao; Dan-Dan Yang; Hui Yan; Juan Ji; Xiu-Lan Sun
Journal:  J Neuroinflammation       Date:  2016-03-09       Impact factor: 8.322

Review 6.  Therapeutic Effects of Resveratrol on Ischemia-Reperfusion Injury in the Nervous System.

Authors:  Alireza Sarkaki; Mojtaba Rashidi; Mina Ranjbaran; Aram Asareh Zadegan Dezfuli; Zahra Shabaninejad; Ebrahim Behzad; Maryam Adelipour
Journal:  Neurochem Res       Date:  2021-08-07       Impact factor: 3.996

7.  Design and Methodology of a Multicenter Randomized Clinical Trial to Evaluate the Efficacy of Tongmai Jiangtang Capsules in Type 2 Diabetic Coronary Heart Disease Patients.

Authors:  Yu Wang; Yilei Guo; Ye Lei; Shuwei Huang; Liping Dou; Chang Li; Buchang Zhao; Wei Fu; Peng Zhou; Haitong Wan; Mingjun Zhao; Jiehong Yang
Journal:  Front Pharmacol       Date:  2021-06-03       Impact factor: 5.810

8.  Traditional Chinese medicine Bu-Shen-Jian-Pi-Fang attenuates glycolysis and immune escape in clear cell renal cell carcinoma: results based on network pharmacology.

Authors:  Jinzhou Zheng; Wenhao Xu; Wangrui Liu; Haijia Tang; Jingen Lu; Kui Yu; Xiaoyun Song; Feng Li; Yu Wang; Rui Wang; Lili Chen; Hailiang Zhang; Yunhua Qiu; Gaomeng Wei; Xiqiu Zhou; Jianfeng Yang
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

Review 9.  Anti-Inflammation of Natural Components from Medicinal Plants at Low Concentrations in Brain via Inhibiting Neutrophil Infiltration after Stroke.

Authors:  Jiannan Chen; Xiangjian Zhang; Cong Zhang; Wenhui Wang; Rong Chen; Honglei Jiao; Linlin Li; Lan Zhang; Lili Cui
Journal:  Mediators Inflamm       Date:  2016-09-05       Impact factor: 4.711

10.  A retrospective cohort study on the outcomes of ischemic stroke patients with adjuvant Korean Medicine treatment.

Authors:  Ye-Seul Lee; Seungwon Kwon; Younbyoung Chae; Bo-Hyoung Jang; Seong-Gyu Ko
Journal:  Sci Rep       Date:  2018-01-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.